StratDeck

Two stocks in Healthcare

Convatec Group vs Hikma Pharmaceuticals: profit, growth, debt and price compared

Hikma Pharmaceuticals is stronger on 4 of 7 figures: profit margin, debt, price for its expected profit and dividend. Convatec Group is stronger on 2: sales growth and price trend.

Figures as of 18 November 2026Yahoo Finance
Explore Convatec Group's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Convatec Group and Hikma Pharmaceuticals side by side
Convatec GroupCTEC.LHikma PharmaceuticalsHIK.L
Net margin5.0%Stronger: 11.3%
Revenue growth, past yearStronger: +4.40%+4.20%
Debt to equity121.8%Stronger: 77.1%
Forward P/E15.7×Stronger: 9.2×
Dividend yield2.25%Stronger: 3.84%
AnalystsStrong buy · 19Strong buy · 12
From its 200-day averageStronger: +17.9%+5.8%

Share price over the past year

  • Convatec Group+15.1%
  • Hikma Pharmaceuticals+7.7%

20 Nov 202518 Nov 2026

Convatec Group or Hikma Pharmaceuticals: which is stronger?

  • HIK.L

    Which is more profitable?

    Hikma Pharmaceuticals keeps more of each sale as profit: 11.3% against 5.0%.

  • CTEC.L

    Which is growing its sales faster?

    Convatec Group is growing its sales faster: +4.40% over the past year, against +4.20%.

  • HIK.L

    Which has borrowed less?

    Hikma Pharmaceuticals has borrowed less: its debt is 77.1% of what its shareholders own, against 121.8% for Convatec Group.

  • HIK.L

    Which costs less for the profit it is expected to make?

    Hikma Pharmaceuticals costs less for the profit it is expected to make: 9.2× its forward earnings, against 15.7×.

  • HIK.L

    Which pays more in dividends?

    Hikma Pharmaceuticals pays more back in dividends for what a share costs: 3.84% a year, against 2.25%.

  • Which do analysts rate higher?

    Analysts rate both the same: Strong buy.

  • CTEC.L

    Which is in the stronger price trend?

    Convatec Group's price is in the stronger trend: 17.9% above its 200-day average, against 5.8% above.

What each company does

CTEC.LConvatec Group

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally.

Reports results on 23 February 2027

HIK.LHikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

Reports results on 25 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every UK healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.